Clinical Trial Update: Descriptive Study of Cardiac Output During Rehydration With Recombinant Human Hyaluronidase in Pediatrics [Phase 4]

View source ↗

Summary

A Phase 4 descriptive trial examining cardiac output during rehydration with recombinant human hyaluronidase in pediatric dehydration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Output Disorders
• Dehydration
• Pediatrics

Drugs mentioned

• Recombinant human hyaluronidase (recombinant human hyaluronidase (rHuPH20))

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Dehydration, Cardiac Output | Phase 4 | Status: COMPLETED | Results posted: 2017-06-26